Karell Curbelo, ARNP
NPI 1740526714 · Adult Health Nurse Practitioner · Miami, FL
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Karell Curbelo, ARNP is a Adult Health Nurse Practitioner provider in Miami, FL (NPI 1740526714).
Provider details
- NPI number
- 1740526714
- Entity type
- Individual
- Primary specialty
- Adult Health Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- ARNP
- Sex
- Male
- Sole proprietor
- No
- License
- ARNP9249595 (FL)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
13 yrs in NPPES registry
- Profile completeness33% of score
100% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Bictegrav/Emtricit/Tenofov Alabrand: Biktarvy | 53 |
| Valacyclovir Hclbrand: Valacyclovir | 26 |
| Dolutegravir/Rilpivirinebrand: Juluca | 19 |
| Atorvastatin Calcium | 15 |
| Abacavir/Dolutegravir/Lamivudibrand: Triumeq | 13 |
| Tamsulosin Hcl | 12 |
| Fenofibrate Nanocrystallizedbrand: Fenofibrate | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$572 across 25 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2012-12-20
- Last updated
- 2013-01-24
Frequently asked questions
- What is Karell Curbelo's NPI number?
- Karell Curbelo's National Provider Identifier (NPI) is 1740526714, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Karell Curbelo's specialty?
- Karell Curbelo is listed in the NPPES registry with a primary specialty of Adult Health Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).
- Where is Karell Curbelo located?
- Karell Curbelo's practice location on file with NPPES is 1400 Nw 12th Ave, Miami, FL 33136-1003.
- What is Karell Curbelo's phone number?
- The practice phone number listed in the NPPES registry for Karell Curbelo is (305) 689-5464.
- Does Karell Curbelo accept Medicare?
- Karell Curbelo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Karell Curbelo's NPI active?
- Yes — Karell Curbelo's NPI (1740526714) is active in the NPPES registry as of the last update on 2013-01-24.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.